Ordering from outside the Americas?Switch to the EU store
Recovery & RepairBp
BPC-157 10mg
vial · 10 mg
◉Lot numberedLot on every label
✓Research use onlyIn vitro only
❄Cold-chain shippingInsulated, tracked

BPC-157

In stockBody Protection Compound 157

Synthetic 15-residue peptide, described in the literature as a partial sequence of body protection compound (BPC) from human gastric juice. Researchers study it in rodent and cell-culture work on tendon cells and vessel formation.

Select format
Select content
Choose quantity · save more
Need solvent? Add extra below
$69.00
$81.00 more for free shipping

In stock

SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-ValCAS137525-51-0FormulaC62H98N16O22AliasesBody Protection Compound 157, PL 14736, BPC 157FormatvialContent10 mg

Supplied as a single-chamber lyophilized vial with a colour-coded cap (Recovery & Repair).

Questions about BPC-157

How much published research is there on BPC-157?

The research library's PubMed search for BPC-157 returned 226 records on 5 October 2026, 50 of them reviews. The library lists 8 studies chosen for what they measured. ClinicalTrials.gov lists 4 registered studies naming BPC-157 (checked 5 October 2026).

Is BPC-157 an approved medicine?

No medicinal product containing BPC-157 is listed in Drugs@FDA (checked 5 October 2026), and the research material we supply is not a medicine. It is supplied for in-vitro laboratory research only, not for human or veterinary use.

Is BPC-157 the same as body protection compound?

BPC-157 is the synthetic 15-residue peptide listed here. The literature describes it as a partial sequence of body protection compound (BPC), isolated from human gastric juice. Published work on BPC-157 is mostly rodent and cell-culture research.

How does BPC-157 differ from TB-500?

BPC-157 is a 15-residue synthetic peptide described as a partial sequence of a gastric protein. TB-500 is the name used for synthetic thymosin beta 4, a 43-residue actin-binding peptide. They differ in origin, size and literature, and one rat study has compared each with the combination.

How is the identity of BPC-157 confirmed on a certificate?

A research-grade certificate of analysis typically reports identity by mass spectrometry and purity by HPLC. The mass result is read against the average molecular weight of 1419.5 Da listed on this page. The research library's guide to reading a certificate explains each field.

What other names is BPC-157 published under?

BPC-157 is also written Body Protection Compound 157, PL 14736 and BPC 157. The catalog lists it under the name BPC-157.

Is this product for human use?

No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.

Where can I find shipping information?

Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.

For research use only. Not for human or veterinary use.

What is BPC-157?

BPC-157 is a synthetic 15-residue peptide, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, described in the literature as a partial sequence of body protection compound (BPC), isolated from human gastric juice. Published work is mostly rodent and cell-culture research. We supply BPC-157 as a lyophilized vial for in-vitro laboratory research only.

What are the chemical identifiers of BPC-157?

BPC-157 has the molecular formula C62H98N16O22, an average molecular weight of 1419.5 Da and CAS number 137525-51-0.

Chemistry checked against PubChem (CID 9941957), 5 October 2026; full chemistry record in the research library.

What does published research on BPC-157 cover?

A PubMed search for BPC-157 returned 226 records on 5 October 2026, 50 of them reviews. Our research library lists 8 of these studies, chosen for what they measured.

  • In cultured rat tendon cells BPC 157 was examined for effects on tendon outgrowth, cell survival and cell migration. (Chang et al., J Appl Physiol (1985), 2011; PMID 21030672)
  • In tendon fibroblasts isolated from rat Achilles tendon the study measured growth hormone receptor expression. (Chang et al., Molecules, 2014; PMID 25415472)
  • In chorioallantoic membrane and endothelial tube-formation assays the study measured vessel formation, and VEGFR2 expression and activation. (Hsieh et al., J Mol Med (Berl), 2017; PMID 27847966)
  • A 2026 study reports an FBXO22 and BACH1 pathway in the pro-angiogenic mechanism, in endothelial cells and animal models. (Zhang et al., Cell Commun Signal, 2026; PMID 41606641)

Mechanism, every cited study and the regulator records are on the BPC-157 page of the research library. Papers are listed by what they measured, not as evidence of any use.

How is BPC-157 supplied and stored?

BPC-157 is supplied as a lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.

What is the regulatory status of BPC-157?

Drugs@FDA lists no application naming BPC-157 or BPC 157 as an active ingredient (checked 5 October 2026).

The WADA 2026 Prohibited List names this substance under S0. A WADA entry is a sporting rule, not a statement about legality outside sport.

A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.

Which related research pages and compounds are listed?

Related compounds in the catalog: